DD:NYE-E.I. du Pont de Nemours and Company (USD)

EQUITY | Specialty Chemicals | New York Stock Exchange

Last Closing

USD 77.67

Change

0.00 (0.00)%

Market Cap

USD 61.52B

Volume

2.00M

Analyst Target

USD 64.25
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

E.I. du Pont de Nemours & Co is a science and technology based company. It offers products and patents applications for agriculture, nutrition, electronics and communications, safety and protection, home and construction, transportation and others.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
SHW Sherwin-Williams Co

-1.62 (-0.52%)

USD 80.88B
ECL Ecolab Inc

+1.03 (+0.44%)

USD 66.51B
APD Air Products and Chemicals Inc

+5.66 (+2.20%)

USD 58.40B
LYB LyondellBasell Industries NV

+0.97 (+0.97%)

USD 33.01B
PPG PPG Industries Inc

-0.34 (-0.25%)

USD 31.73B
DLY DoubleLine Yield Opportunities..

-0.07 (-0.44%)

USD 27.84B
IFF International Flavors & Fragra..

+1.86 (+1.90%)

USD 24.83B
WLK Westlake Chemical Corporation

+2.77 (+1.79%)

USD 19.92B
AVTR Avantor Inc

+0.01 (+0.04%)

USD 16.97B
ALB Albemarle Corp

+1.93 (+1.49%)

USD 15.18B

ETFs Containing DD

FRFD:LSE Franklin Future of Food U.. 4.21 % 0.00 %

-0.05 (-0.27%)

USD 2.48M
RTM Invesco S&P 500® Equal W.. 3.75 % 0.40 %

+0.21 (+-0.27%)

USD 0.30B
5HED:SW Ossiam ESG LC Shiller Bar.. 3.72 % 0.00 %

N/A

N/A
RSPM Invesco S&P 500® Equal.. 3.62 % 0.00 %

+0.21 (+-0.27%)

USD 0.29B
XDRV:CA iShares Global Electric a.. 3.57 % 0.00 %

N/A

CAD 5.03M
5HEE:SW Ossiam ESG LC Shiller Bar.. 3.50 % 0.00 %

-0.10 (-0.27%)

N/A
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.00 %

-141.00 (-0.27%)

USD 0.35B
VCIT Vanguard Intermediate-Ter.. 0.10 % 0.07 %

-0.11 (-0.27%)

USD 44.68B
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

+0.01 (+-0.27%)

USD 0.40B
VCSH Vanguard Short-Term Corpo.. 0.08 % 0.07 %

-0.04 (-0.27%)

USD 34.03B
VCLT Vanguard Long-Term Corpor.. 0.07 % 0.07 %

-0.31 (-0.27%)

USD 8.47B
SCHZ Schwab U.S. Aggregate Bon.. 0.01 % 0.04 %

-0.09 (-0.27%)

USD 7.52B
BIV Vanguard Intermediate-Ter.. 0.00 % 0.07 %

-0.14 (-0.27%)

USD 17.27B
BLV Vanguard Long-Term Bond I.. 0.00 % 0.07 %

-0.32 (-0.27%)

USD 5.51B
BSV Vanguard Short-Term Bond .. 0.00 % 0.07 %

-0.06 (-0.27%)

USD 32.23B
IBDO 0.00 % 0.10 %

N/A

N/A
JHMA 0.00 % 0.47 %

N/A

N/A
RFCI RiverFront Dynamic Core I.. 0.00 % 0.51 %

-0.04 (-0.27%)

USD 0.02B
BASE:CA Evolve Global Materials &.. 0.00 % 0.00 %

+0.21 (+-0.27%)

CAD 0.05B
BASE-B:CA Evolve Global Materials &.. 0.00 % 0.00 %

+0.10 (+-0.27%)

CAD 0.08B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-3.20 (-0.27%)

USD 0.05B
SBM 0.00 % 0.95 %

N/A

N/A
SMN ProShares UltraShort Basi.. 0.00 % 0.95 %

-0.10 (-0.27%)

USD 0.98M
UC97:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-0.04 (-0.27%)

USD 0.18B
UC98:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-6.25 (-0.27%)

USD 0.18B
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

-0.06 (-0.27%)

USD 6.44B
ABEQ Absolute Core Strategy ET.. 0.00 % 0.00 %

+0.20 (+-0.27%)

USD 0.09B
LSAT Two Roads Shared Trust - .. 0.00 % 0.00 %

+0.05 (+-0.27%)

USD 0.15B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.96% 49% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.96% 47% F 38% F
Trailing 12 Months  
Capital Gain 18.56% 67% D+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.56% 63% D 65% D
Trailing 5 Years  
Capital Gain -7.46% 33% F 38% F
Dividend Return 4.00% 13% F 13% F
Total Return -3.46% 28% F 25% F
Average Annual (5 Year Horizon)  
Capital Gain 8.61% 57% F 67% D+
Dividend Return 9.74% 52% F 64% D
Total Return 1.13% 29% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 32.65% 57% F 33% F
Risk Adjusted Return 29.84% 57% F 52% F
Market Capitalization 61.52B 89% A- 92% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.70 2% 9%
Price/Book Ratio 1.27 76% 60%
Price / Cash Flow Ratio 14.10 33% 26%
Price/Free Cash Flow Ratio 17.69 16% 19%
Management Effectiveness  
Return on Equity 2.06% 20% 33%
Return on Invested Capital 5.24% 31% 46%
Return on Assets 2.67% 20% 52%
Debt to Equity Ratio 31.84% 90% 72%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector